Teva Presents New AUSTEDO® and AUSTEDO XR® Data Showing Patient- and Caregiver-Reported Improvements in Huntington’s Disease Chorea Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), has announced new real-world evidence demonstrating that treatment with…
Feinstein Institutes’ John M. Kane Receives 2026 Schizophrenia International Research Society Lifetime Achievement Award John M. Kane, MD, a leading figure in schizophrenia research and co-director of the Institute of Behavioral Science at Northwell Health’s Feinstein Institutes for Medical Research,…
Glooko Launches First-Ever Insulin Pump Settings EHR Integration to Streamline Clinical Workflows and Data Access Glooko, Inc., a global digital health company focused on improving diabetes management and supporting clinicians in addressing glycemic safety across the full continuum of care,…
VB Spine Partners to Fund Breakthrough Pediatric Scoliosis Genetics Research Led by Dr. Alain Moreau VB Spine LLC, a global, family-owned spine-focused medical company, has announced a strategic partnership to fund advanced research into the molecular genetics of pediatric scoliosis.…
Cellares and TScan Therapeutics Collaborate to Evaluate Automated Manufacturing for TSC-101 TCR-T Therapy in AML and MDS Cellares, the first Integrated Development and Manufacturing Organization (IDMO), and TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company developing T cell receptor-engineered…
DocGo Expands PTI Health Mobile Phlebotomy Services Into Southern Florida Through Expanded Laboratory Partnership DocGo Inc., a leading provider of technology-enabled mobile health services and medical transportation solutions, has announced the launch of mobile phlebotomy services in Southern Florida through…
Gilead Reports Positive Phase 3 Results for Livdelzi in Primary Biliary Cholangitis, Demonstrating Significant Improvement in Liver Disease Marker Gilead Sciences has announced positive topline results from the Phase 3 IDEAL clinical trial evaluating Livdelzi® (seladelpar) in patients with primary…
Hims & Hers Completes Acquisition of Eucalyptus, Strengthening Clinically Supported Weight Management Services in Germany Hims & Hers Health, Inc. has officially completed its acquisition of Eucalyptus, the parent company behind Juniper, marking a significant milestone in the company’s international…
C2N Diagnostics and SouthGenetics Partner to Expand Access to Alzheimer’s Blood Biomarker Testing Across Latin America and the Caribbean C2N Diagnostics, LLC, a specialty diagnostics company focused on advancing blood-based biomarker testing for neurodegenerative diseases, has announced a strategic collaboration…
Corcept Therapeutics Reports Statistically Significant Overall Survival Benefit for Lifyorli in Platinum-Resistant Ovarian Cancer at ASCO 2026 Corcept Therapeutics Incorporated, a commercial-stage biopharmaceutical company focused on discovering and developing therapies that modulate the effects of cortisol, has announced compelling new…
Virion Therapeutics Reports Durable Functional Cure Signals in Chronic Hepatitis B with Single-Dose VRON-0200 at EASL 2026 Virion Therapeutics, LLC, a clinical-stage biotechnology company focused on developing next-generation T cell–based immunotherapies for chronic viral diseases, has announced compelling long-term clinical…
Canopy Growth Relaunches Tweed Brand in Germany and Expands Medical Cannabis Portfolio Following MTL Acquisition Canopy Growth Corporation has announced a major strategic milestone in its international expansion strategy with the relaunch of its Tweed brand in the German medical…